1
|
Massaro A, Peruzzo A, Zacometti C, Zancato M, Piro R, Losasso C, Tata A, Peron G. Exploring the crosstalk between gut microbiota and stool metabolome in omnivorous, vegetarian, and vegan diets: a pilot study. J Nutr Biochem 2025:109965. [PMID: 40398824 DOI: 10.1016/j.jnutbio.2025.109965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2024] [Revised: 03/11/2025] [Accepted: 05/16/2025] [Indexed: 05/23/2025]
Abstract
Gut microbiota (GM) and fecal metabolome are shaped by different dietary regimens. Nevertheless, outlining generalized patterns is challenging, due to the intrinsic heterogeneity of individual dietary choices. In this work, the fecal metabolome of adult volunteers consuming omnivorous (n = 44), vegetarian (n = 29), and vegan diets (n = 25) for at least 12 months was characterized. The crosstalk among diet, GM and fecal metabolome was also investigated correlating metabolomics and metataxonomics data. Untargeted metabolomic profiles were correlated with metataxonomics data previously acquired on the same stool samples. The sphingomyelin SM(d18:2/18:1-2OH) and phosphoethanolamines from animal-based food were associated to the omnivorous diet and were negatively correlated to beneficial Bacteroides ovatus and Odoribacter genus. Plant glycerides, sterols, triterpenes, and oleic-linoleic acid were associated with the vegan diet. Oleic-linoleic acid was positively correlated with Alistipes putredinis. Chenodeoxycholic acid, a primary bile acid, was identified as a marker of vegan diet, while ketolithocholic acid, a secondary bile acid, was associated to the omnivorous diet. This latter was also negatively correlated to B.ovatus. Overall, results confirm that assessing markers of dietary regimens instead of specific food categories is challenging, especially if volunteers' diet is not strictly monitored. However, the integration of metabolomics and metataxonomic data allows to better understand the effects of specific food components on the GM and represents a suitable approach for further molecular investigation in nutrition.
Collapse
Affiliation(s)
- Andrea Massaro
- Istituto Zooprofilattico Sperimentale delle Venezie, Laboratorio di Chimica Sperimentale, Vicenza, Italy..
| | - Arianna Peruzzo
- Laboratory of Microbial Ecology and genomics, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.; PhD National Programme in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
| | - Carmela Zacometti
- Istituto Zooprofilattico Sperimentale delle Venezie, Laboratorio di Chimica Sperimentale, Vicenza, Italy..
| | - Mirella Zancato
- Department of Pharmaceutical Sciences, University of Padua, Italy..
| | - Roberto Piro
- Istituto Zooprofilattico Sperimentale delle Venezie, Laboratorio di Chimica Sperimentale, Vicenza, Italy..
| | - Carmen Losasso
- Laboratory of Microbial Ecology and genomics, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy..
| | - Alessandra Tata
- Istituto Zooprofilattico Sperimentale delle Venezie, Laboratorio di Chimica Sperimentale, Vicenza, Italy..
| | - Gregorio Peron
- Department of Molecular and Translational Medicine, University of Brescia, Italy..
| |
Collapse
|
2
|
Huang Z, Du X, Li F, Lan Z, Guo L, Pan L. Gut microbiota and blood metabolites: unveiling their roles in hippocampal volume changes through Mendelian randomization and mediation analysis. Metab Brain Dis 2025; 40:178. [PMID: 40220127 DOI: 10.1007/s11011-025-01611-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2025] [Accepted: 04/08/2025] [Indexed: 04/14/2025]
Abstract
Changes in hippocampal volume (HV) are linked to various neuropsychiatric disorders. Observational studies suggest associations of gut microbiota (GM) and blood metabolites (BM) with changes in HV; however, their causal relationships remain unclear. We aimed to use Mendelian randomization (MR) to investigate the causal associations of GM and BM with changes in HV and to explore the potential mediating role of BM. Using two-sample MR (TSMR) analysis, we examined 412 GM traits and 1,400 BM traits with a focus on their causal relationships with age-independent/dependent longitudinal changes in HV, primarily using the inverse variance weighted method. Furthermore, we explored the mediating role of BM through a two-step MR design. We identified 44 GM traits and 175 BM traits having nominally significant causal associations with age-independent/dependent longitudinal changes in HV. In addition, the glycine-to-pyridoxal ratio (mediation proportion: 7.38%) and the phosphate-to-citrate ratio (mediation proportion: 12.55%) mediated the effect of the pathway of L-arginine degradation II on the reduction of age-independent longitudinal changes in HV. Our study reveals the causal effects of GM and BM on longitudinal changes in HV and identifies BM traits with mediating roles. These findings offer valuable insights for the prevention and treatment of the related neuropsychiatric disorders.
Collapse
Affiliation(s)
- Zijin Huang
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China
- Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530007, People's Republic of China
- Guangxi Key Laboratory for Basic Science and Prevention of Perioperative Organ Dysfunction, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
- Guangxi Engineering Research Center for Tissue & Organ Injury and Repair Medicine, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China
- Guangxi Clinical Research Center for Anesthesiology, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - Xueke Du
- Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530007, People's Republic of China
- Guangxi Key Laboratory for Basic Science and Prevention of Perioperative Organ Dysfunction, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - Fangzhou Li
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China
- Guangxi Key Laboratory for Basic Science and Prevention of Perioperative Organ Dysfunction, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
- Guangxi Engineering Research Center for Tissue & Organ Injury and Repair Medicine, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China
- Guangxi Clinical Research Center for Anesthesiology, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - Zhixuan Lan
- Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530007, People's Republic of China
| | - Liang Guo
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China
- Guangxi Key Laboratory for Basic Science and Prevention of Perioperative Organ Dysfunction, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
- Guangxi Engineering Research Center for Tissue & Organ Injury and Repair Medicine, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China
- Guangxi Clinical Research Center for Anesthesiology, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - Linghui Pan
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
- Guangxi Key Laboratory for Basic Science and Prevention of Perioperative Organ Dysfunction, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
- Guangxi Engineering Research Center for Tissue & Organ Injury and Repair Medicine, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
- Guangxi Clinical Research Center for Anesthesiology, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
| |
Collapse
|
3
|
Li J, Xu J, Guo X, Xu H, Huang C, Nie Y, Zhou Y. Odoribacter splanchnicus-A Next-Generation Probiotic Candidate. Microorganisms 2025; 13:815. [PMID: 40284651 PMCID: PMC12029356 DOI: 10.3390/microorganisms13040815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2025] [Revised: 03/27/2025] [Accepted: 04/01/2025] [Indexed: 04/29/2025] Open
Abstract
As an important intestinal microorganism, Odoribacter splanchnicus frequently appears in high-throughput sequencing analyses, although pure culture research on this microorganism is not as advanced. It is widely present in the mammalian gut and is closely associated with the health status of the host and the incidence of various diseases. In recent years, changes in the abundance of O. splanchnicus have been found to be positively or negatively correlated with health issues, such as obesity, metabolic syndrome, diabetes, and intestinal inflammation. It may exhibit a dual protective or promotional role in specific diseases. Thus, it may play an important role in regulating host metabolism, immune response, and intestinal homeostasis. Additional research has revealed that O. splanchnicus can synthesize various metabolites, especially short-chain fatty acids (SCFAs), which play a key role in promoting intestinal health, enhancing energy metabolism, improving insulin resistance, and regulating immune responses in the host. Therefore, O. splanchnicus is a strong candidate for "next-generation probiotics", and its potential probiotic function provides novel ideas for the development of functional foods and the prevention and treatment of metabolic and intestinal inflammatory diseases. These findings can help develop new biological treatment strategies and optimize health management plans.
Collapse
Affiliation(s)
- Jianhong Li
- Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510006, China; (J.L.); (J.X.); (X.G.); (H.X.); (C.H.)
- Department of Gastroenterology and Hepatology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou 510180, China
| | - Jing Xu
- Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510006, China; (J.L.); (J.X.); (X.G.); (H.X.); (C.H.)
- Department of Gastroenterology and Hepatology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou 510180, China
| | - Xue Guo
- Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510006, China; (J.L.); (J.X.); (X.G.); (H.X.); (C.H.)
- Department of Gastroenterology and Hepatology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou 510180, China
| | - Haoming Xu
- Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510006, China; (J.L.); (J.X.); (X.G.); (H.X.); (C.H.)
- Department of Gastroenterology and Hepatology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou 510180, China
| | - Chen Huang
- Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510006, China; (J.L.); (J.X.); (X.G.); (H.X.); (C.H.)
- Department of Gastroenterology and Hepatology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou 510180, China
| | - Yuqiang Nie
- Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510006, China; (J.L.); (J.X.); (X.G.); (H.X.); (C.H.)
- Department of Gastroenterology and Hepatology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou 510180, China
| | - Youlian Zhou
- Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510006, China; (J.L.); (J.X.); (X.G.); (H.X.); (C.H.)
- Department of Gastroenterology and Hepatology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou 510180, China
| |
Collapse
|
4
|
Toussaint Nguélé A, Mozzicafreddo M, Carrara C, Piersanti A, Salum SS, Ali SM, Miceli C. Interplay Between Helminth Infections, Malnutrition, and Gut Microbiota in Children and Mothers from Pemba, Tanzania: Potential of Microbiota-Directed Interventions. Nutrients 2024; 16:4023. [PMID: 39683417 DOI: 10.3390/nu16234023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2024] [Revised: 11/20/2024] [Accepted: 11/21/2024] [Indexed: 12/18/2024] Open
Abstract
BACKGROUND/OBJECTIVES Despite efforts within the framework of the Sustainable Development Goal to end malnutrition by 2030, malnutrition and soil-transmitted helminth infections persist in sub-Saharan Africa. A significant barrier to success is the inadequate understanding of effective intervention methods. Most research on the gut microbiota's role in health has been conducted in developed countries, leaving a critical gap in knowledge regarding low-income populations. This study addresses this gap by expanding research on the gut microbiota of underprivileged populations to help tackle these public health challenges. METHODS We employed 16S rDNA sequencing to assess the bacterial gut microbiota composition of 60 children (mean age: 26.63 ± 6.36 months) and their 58 mothers (mean age: 30.03 ± 6.31 years) in Pemba, with a focus on helminth infection and nutritional status. RESULTS Our differential abundance analysis identified bacterial taxa that were significantly negatively associated with both helminth infections and malnutrition, highlighting the potential for microbiota-directed interventions to address these health issues simultaneously. Notably, we identified Akkermansia, Blautia, Dorea, and Odoribacter as promising probiotic candidates for such interventions. In stunted children, positive co-occurrences were observed between Lactobacillus, Prevotella, and Bacteroides, while Escherichia/Shigella displayed negative co-abundance relationships with short-chain fatty acid (SCFA) producers in the gut microbiota. These findings suggest that administering Lactobacillus and SCFA-producing probiotics to children may foster the growth of beneficial bacteria like Prevotella and Bacteroides while reducing the relative abundance of Escherichia/Shigella, potentially enhancing overall health. CONCLUSIONS This study underscores the importance of microbiota-directed interventions in children and women of reproductive age as promising strategies, alongside established approaches, for combating helminth infections and malnutrition in vulnerable populations.
Collapse
Affiliation(s)
- Aristide Toussaint Nguélé
- School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy
- Institut Supérieur des Sciences de la Santé, Université Adventiste Cosendai, Nanga Eboko 04, Cameroon
| | - Matteo Mozzicafreddo
- Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy
| | - Chiara Carrara
- School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy
| | - Angela Piersanti
- School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy
- Department of Biology, University of Padova, 35121 Padova, Italy
| | - Salum Seif Salum
- School of Health and Medical Sciences, State University of Zanzibar, Zanzibar City 146, Tanzania
| | - Said M Ali
- Public Health Laboratory Ivo de Carneri, Chake Chake 122, Tanzania
| | - Cristina Miceli
- School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy
| |
Collapse
|
5
|
Peng S, Guo C, Zhang X, Bu X, Li X, Cui H, Duan Z. Kinetic study of the thermal inactivation of Weizmannia coagulans during food thermal processing. Heliyon 2024; 10:e36977. [PMID: 39286079 PMCID: PMC11402908 DOI: 10.1016/j.heliyon.2024.e36977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 08/25/2024] [Accepted: 08/26/2024] [Indexed: 09/19/2024] Open
Abstract
Weizmannia coagulans has attracted attention due to its remarkable health benefits for human, but the dynamic changes of its viable bacteria during thermal processing have been less reported. In this study, a predictive model for the survival of Weissmanella coagulans during thermal processing of food was developed and validated during the processing of coffee, tea, instant noodles, calcium milk biscuits, muffin cake and steamed buns. The kinetics of heat inactivation activities of Weizmannia coagulans VHProbi C08 and Weizmannia coagulans GBI-30, 6086 at 85, 95, 105, 110 and 115 °C were investigated, and their coefficients of determination were greater than 0.91 and 0.87, and the root-mean-square errors were less than 0.64 and 0.43, respectively. The z-values of VHProbi C08 and GBI-30, 6086 were obtained by Bigelow model fitting as 36.1 °C and 36.9 °C, respectively. The developed prediction model was applied to the thermal processing of six food products and the measured values were all within ±0.5 Log10 (CFU/mL) of the predicted values, indicating high prediction accuracy. The model predicts the survival of Weissmanella coagulans simply by obtaining the initial number of viable bacteria and the change in temperature. These suggested that the model can be used as an effective tool to evaluate the stability of Weizmannia coagulans in food thermal processing.
Collapse
Affiliation(s)
- Shudong Peng
- School of Food Science and Engineering, South China University of Technology, Guangzhou, China
| | - Chaoqun Guo
- Qingdao Vland Biotech Inc. Nutrition & Health Technology Center, Qingdao, China
| | - Xiaoyuan Zhang
- School of Food Science and Engineering, South China University of Technology, Guangzhou, China
| | - Xinping Bu
- Qingdao Vland Biotech Inc. Nutrition & Health Technology Center, Qingdao, China
| | - Xinping Li
- Qingdao Vland Biotech Inc. Nutrition & Health Technology Center, Qingdao, China
| | - Hongchang Cui
- Qingdao Vland Biotech Inc. Nutrition & Health Technology Center, Qingdao, China
| | - Zhi Duan
- Qingdao Vland Biotech Inc. Nutrition & Health Technology Center, Qingdao, China
| |
Collapse
|
6
|
Moutaharrik S, Palugan L, Cerea M, Meroni G, Casagni E, Roda G, Martino PA, Gazzaniga A, Maroni A, Foppoli A. Colon Drug Delivery Systems Based on Swellable and Microbially Degradable High-Methoxyl Pectin: Coating Process and In Vitro Performance. Pharmaceutics 2024; 16:508. [PMID: 38675167 PMCID: PMC11054370 DOI: 10.3390/pharmaceutics16040508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Revised: 03/30/2024] [Accepted: 04/02/2024] [Indexed: 04/28/2024] Open
Abstract
Oral colon delivery systems based on a dual targeting strategy, harnessing time- and microbiota-dependent release mechanisms, were designed in the form of a drug-containing core, a swellable/biodegradable polysaccharide inner layer and a gastroresistant outer film. High-methoxyl pectin was employed as the functional coating polymer and was applied by spray-coating or powder-layering. Stratification of pectin powder required the use of low-viscosity hydroxypropyl methylcellulose in water solution as the binder. These coatings exhibited rough surfaces and higher thicknesses than the spray-coated ones. Using a finer powder fraction improved the process outcome, coating quality and inherent barrier properties in aqueous fluids. Pulsatile release profiles and reproducible lag phases of the pursued duration were obtained from systems manufactured by both techniques. This performance was confirmed by double-coated systems, provided with a Kollicoat® MAE outer film that yielded resistance in the acidic stage of the test. Moreover, HM pectin-based coatings manufactured by powder-layering, tested in the presence of bacteria from a Crohn's disease patient, showed earlier release, supporting the role of microbial degradation as a triggering mechanism at the target site. The overall results highlighted viable coating options and in vitro release characteristics, sparking new interest in naturally occurring pectin as a coating agent for oral colon delivery.
Collapse
Affiliation(s)
- Saliha Moutaharrik
- Department of Pharmaceutical Sciences, Section of Pharmaceutical Technology and Legislation “M.E. Sangalli”, University of Milan, Via G. Colombo 71, 20133 Milan, Italy
| | - Luca Palugan
- Department of Pharmaceutical Sciences, Section of Pharmaceutical Technology and Legislation “M.E. Sangalli”, University of Milan, Via G. Colombo 71, 20133 Milan, Italy
| | - Matteo Cerea
- Department of Pharmaceutical Sciences, Section of Pharmaceutical Technology and Legislation “M.E. Sangalli”, University of Milan, Via G. Colombo 71, 20133 Milan, Italy
| | - Gabriele Meroni
- Department of Biomedical, Surgical and Dental Sciences, One Health Unit, University of Milan, Via Pascal 36, 20133 Milan, Italy
| | - Eleonora Casagni
- Department of Pharmaceutical Sciences, Section of Medicinal Chemistry “P. Pratesi”, University of Milan, Via Trentacoste 2, 20134 Milan, Italy
| | - Gabriella Roda
- Department of Pharmaceutical Sciences, Section of Medicinal Chemistry “P. Pratesi”, University of Milan, Via Trentacoste 2, 20134 Milan, Italy
| | - Piera Anna Martino
- Department of Biomedical, Surgical and Dental Sciences, One Health Unit, University of Milan, Via Pascal 36, 20133 Milan, Italy
| | - Andrea Gazzaniga
- Department of Pharmaceutical Sciences, Section of Pharmaceutical Technology and Legislation “M.E. Sangalli”, University of Milan, Via G. Colombo 71, 20133 Milan, Italy
| | - Alessandra Maroni
- Department of Pharmaceutical Sciences, Section of Pharmaceutical Technology and Legislation “M.E. Sangalli”, University of Milan, Via G. Colombo 71, 20133 Milan, Italy
| | - Anastasia Foppoli
- Department of Pharmaceutical Sciences, Section of Pharmaceutical Technology and Legislation “M.E. Sangalli”, University of Milan, Via G. Colombo 71, 20133 Milan, Italy
| |
Collapse
|
7
|
Moutaharrik S, Meroni G, Soggiu A, Foppoli A, Cerea M, Palugan L, Caloni F, Martino PA, Gazzaniga A, Maroni A. Guar gum as a microbially degradable component for an oral colon delivery system based on a combination strategy: formulation and in vitro evaluation. Drug Deliv Transl Res 2024; 14:826-838. [PMID: 37824039 DOI: 10.1007/s13346-023-01439-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/24/2023] [Indexed: 10/13/2023]
Abstract
Oral colon delivery has widely been pursued exploiting naturally occurring polysaccharides degraded by the resident microbiota. However, their hydrophilicity may hinder the targeting performance. The aim of the present study was to manufacture and evaluate a double-coated delivery system leveraging intestinal microbiota, pH, and transit time for reliable colonic release. This system comprised a tablet core, a hydroxypropyl methylcellulose (HPMC) inner layer and an outer coating based on Eudragit® S and guar gum. The tablets were loaded with paracetamol, selected as a tracer drug because of the well-known analytical profile and lack of major effects on bacterial viability. The HPMC and Eudragit® S layers were applied by film-coating. Tested for in vitro release, the double-coated systems showed gastroresistance in 0.1 N HCl followed by lag phases of consistent duration in phosphate buffer pH 7.4, imparted by the HPMC layer and synergistically extended by the Eudragit® S/guar gum one. In simulated colonic fluid with fecal bacteria from an inflammatory bowel disease patient, release was faster than in the presence of β-mannanase and in control culture medium. The bacteria-containing fluid was obtained by an experimental procedure making multiple tests possible from a single sampling and processing run. Thus, the study conducted proved the feasibility of the delivery system and ability of guar gum to trigger release in the presence of colon bacteria without impairing the barrier properties of the coating. Finally, it allowed an advantageous simulated colonic fluid preparation procedure to be set up, reducing the time, costs, and complexity of testing and enhancing replicability.
Collapse
Affiliation(s)
- Saliha Moutaharrik
- Dipartimento di Scienze Farmaceutiche, Sezione di Tecnologia e Legislazione Farmaceutiche "M.E. Sangalli", Università degli Studi di Milano, Via G. Colombo 71, 20133, Milan, Italy
| | - Gabriele Meroni
- Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, One Health Unit, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy
| | - Alessio Soggiu
- Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, One Health Unit, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy
| | - Anastasia Foppoli
- Dipartimento di Scienze Farmaceutiche, Sezione di Tecnologia e Legislazione Farmaceutiche "M.E. Sangalli", Università degli Studi di Milano, Via G. Colombo 71, 20133, Milan, Italy
| | - Matteo Cerea
- Dipartimento di Scienze Farmaceutiche, Sezione di Tecnologia e Legislazione Farmaceutiche "M.E. Sangalli", Università degli Studi di Milano, Via G. Colombo 71, 20133, Milan, Italy
| | - Luca Palugan
- Dipartimento di Scienze Farmaceutiche, Sezione di Tecnologia e Legislazione Farmaceutiche "M.E. Sangalli", Università degli Studi di Milano, Via G. Colombo 71, 20133, Milan, Italy
| | - Francesca Caloni
- Dipartimento di Scienze e Politiche Ambientali, Università degli Studi di Milano, Via Celoria 10, 20133, Milan, Italy
| | - Piera Anna Martino
- Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, One Health Unit, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy.
| | - Andrea Gazzaniga
- Dipartimento di Scienze Farmaceutiche, Sezione di Tecnologia e Legislazione Farmaceutiche "M.E. Sangalli", Università degli Studi di Milano, Via G. Colombo 71, 20133, Milan, Italy
| | - Alessandra Maroni
- Dipartimento di Scienze Farmaceutiche, Sezione di Tecnologia e Legislazione Farmaceutiche "M.E. Sangalli", Università degli Studi di Milano, Via G. Colombo 71, 20133, Milan, Italy
| |
Collapse
|